PERFECTHA SUB SKIN LIDOCAINE

PERFECTHA SUB SKIN LIDOCAINE is a resorbable gel:
- Advanced cross-linking technology (E-BRID™) which improves elasticity, stability and durability of the volumising effect in the fabric.
- It has high viscosity and cohesion, ideal for injection into the deep subcutaneous and supraperiosteal plane, allowing structural corrections and significant volume increase.
- Composed of approximately 2,000 gel particles per millilitre, with a high particle size (++++), which provides greater volumetric capacity and structural support.

- SINCLAIR PHARMA
- NAME: PERFECTHA SUB SKIN LIDOCAINE
- COMPOSITION: Hyaluronic acid 20.0 mg/ml, Lidocaine 0.3%.
- PRESENTATION: 3 x 1 ml.
- NEEDLES: 6 x 25G x 13mm.
- INDICATIONS: Indicated for modelling facial contours.
- INJECTION DEPTH: Deep subcutaneous and supraperiosteal plane.
- DURATION: 12 to 18 months.
- USE: Strict medical use.

- Syringe: 3 x 1 ml.
- Needles: 6 x 25G x 13mm.

Face, in particular: cheekbones, chin, jaw, temples, forehead, back of the nose and hands.

Hyaluronic acid 20.0 mg/ml, Lidocaine 0.3%.

- The product may only be administered by a registered and qualified healthcare professional in accordance with local regulations on the administration of dermal fillers
- The injection must be performed with sterile techniques and knowledge of anatomy to minimise the risk of vascular complications or infection
- Before treatment, the doctor must carefully assess the patient's medical history and check for any known allergies or conditions that increase the risk of adverse reactions
- It is important to carefully monitor the treated area during administration to intervene promptly in the event of signs of ischaemia or altered skin perfusion
- The doctor must inform the patient about possible common side effects and actions to be taken in case of adverse reactions after treatment

PERFECTHA SUB SKIN LIDOCAINE is contraindicated in the following cases:
- It should not be mixed with other products before injection as this can alter the functionality of the gel and compromise sterility by increasing the risk of infection
- Should not be injected intramuscularly or intravascularly due to the risk of vascular compression, skin discolouration, necrosis or ulceration in the treated area and risk of embolism in the organs perfused by the affected vessels
- The injection must be stopped immediately if a change in colour or whitening of the skin is observed and the area massaged until normal colouration is restored
- Excessive correction should not be practised as this may increase the risk of aesthetic or clinical complications
- It is not recommended in patients with known hypersensitivity to proteins, feathers or products derived from bird eggs, as such individuals may also be sensitive to sodium hyaluronate in the product

Designed for treating deep skin depressions, increasing volume in areas such as the chin, jaw and cheeks, and for defining facial contours. It is also indicated for the treatment of deep scars and hand rejuvenation.